Ji, J., Wu, H., Feng, X., Liu, X., Huang, C., Zheng, S., . . . Liao, J. (2021). Dynamics of Acquired Resistance to Nivolumab Therapies Varies From Administration Strategies. Clinical therapeutics, 43(12), 2088-2103. https://doi.org/10.1016/j.clinthera.2021.10.004
Chicago Style (17th ed.) CitationJi, Jiatong, Hong Wu, Xiaobing Feng, Xiaoquan Liu, Chenrong Huang, Shuyun Zheng, Jianjun Zou, and Jun Liao. "Dynamics of Acquired Resistance to Nivolumab Therapies Varies From Administration Strategies." Clinical Therapeutics 43, no. 12 (2021): 2088-2103. https://doi.org/10.1016/j.clinthera.2021.10.004.
MLA (9th ed.) CitationJi, Jiatong, et al. "Dynamics of Acquired Resistance to Nivolumab Therapies Varies From Administration Strategies." Clinical Therapeutics, vol. 43, no. 12, 2021, pp. 2088-2103, https://doi.org/10.1016/j.clinthera.2021.10.004.